Baker Tilly advises NanoEntek on acquisition of med-tech supplies

Munich, 21 August 2024 – The international consulting firm Baker Tilly has advised NanoEntek Inc., a South-Korean biotechnology company listed with KOSDAQ and based in Seoul, on the acquisition of all shares in med-tech supplies GmbH, a German medical technology supplier based in Planegg, Germany. Founder and former sole shareholder of med-tech supplies GmbH, Jakob Schwab, remains Managing Director.

The interdisciplinary services provided by the team led by Munich-based partner Dr. Raphael Won-Pil Suh (Lawyer, Corporate, M&A) included legal, tax and financial due diligence, process management, drafting of transaction documents, contract negotiations as well as signing and closing.

The Baker Tilly team led by partner Suh consisted of Stephan Zuber (Partner Corporate, M&A), Uwe Roth (Partner Tax), Sebastian Hafner (Partner Financial), as well as Till Werner,  Jinhoon Jeong, Peter Reiß (all Corporate, M&A), Stefan Lehner,  Markus Cullefors (both Tax), Julian Mair (Financial) as well as Stephanie Breitenbach and Marco Stahn (both employment law).

“We congratulate NanoEntek on this successful acquisition and thank the entire team for their trust and excellent cooperation”, says partner Dr. Raphael Won-Pil Suh, head of Korea Desk at Baker Tilly.

NanoEntek develops medical, biotechnological and diagnostic products, including point-of-care tests and lab-on-a-chip technology that combines micro-electro-mechanical systems (MEMS) and micro-fluidics. More information on NanoEntek can be found here.

Med-tech supplies distributes medical technology, laboratory and diagnostic products and services throughout the DACH region. More information on med-tech supplies can be found here.

German Version (Download PDF)  Korean Version (Download PDF)